Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FOY 251
Cat. No.:
OB0425LY-254
Appearance:
Solid
Purity:
98.86%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
FOY 251 is an anti-proteolytic active metabolite Camostate with anti-viral properties.
Synonyms:
Foy 251; 71079-09-9; 4-(4-Guanidinobenzoyloxy)phenylacetic acid; Foy-251; FOY251; 2-(4-((4-Guanidinobenzoyl)oxy)phenyl)acetic acid methanesulfonic acid salt; 2-[4-[4-(Diaminomethylideneamino)benzoyl]oxyphenyl]acetic acid;methanesulfonic acid
CAS No.:
71079-09-9
Compound CID:
130394
Formula:
C17H19N3O7S
Formula Weight:
409.41
Specification
Target:
Ser/Thr Protease; SARS-CoV
Pathway:
Metabolic enzyme/Protease; Anti-infection
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
FOY 251 can be used to explore its inhibitory effects on specific cancer cells.
